ATE505561T1 - Gen und polypeptid in zusammenhang mit brustkrebs - Google Patents

Gen und polypeptid in zusammenhang mit brustkrebs

Info

Publication number
ATE505561T1
ATE505561T1 AT06782210T AT06782210T ATE505561T1 AT E505561 T1 ATE505561 T1 AT E505561T1 AT 06782210 T AT06782210 T AT 06782210T AT 06782210 T AT06782210 T AT 06782210T AT E505561 T1 ATE505561 T1 AT E505561T1
Authority
AT
Austria
Prior art keywords
gene
breast cancer
polypeptide related
polypeptide
breast
Prior art date
Application number
AT06782210T
Other languages
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Shuichi Nakatsuru
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ATE505561T1 publication Critical patent/ATE505561T1/de

Links

AT06782210T 2005-07-29 2006-07-26 Gen und polypeptid in zusammenhang mit brustkrebs ATE505561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70365805P 2005-07-29 2005-07-29
JP2006015341 2006-07-26

Publications (1)

Publication Number Publication Date
ATE505561T1 true ATE505561T1 (de) 2011-04-15

Family

ID=43825189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06782210T ATE505561T1 (de) 2005-07-29 2006-07-26 Gen und polypeptid in zusammenhang mit brustkrebs

Country Status (1)

Country Link
AT (1) ATE505561T1 (de)

Similar Documents

Publication Publication Date Title
PL2567707T3 (pl) Kompozycja peptydów związanych z guzem i pokrewna szczepionka przeciw rakowi
HRP20130720T1 (en) Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
ATE538137T1 (de) Antikörper gegen menschliches il-22 und verwendungen davon
GB2429207A9 (en) Modified human interferon polypeptides and their uses
ES2869167T8 (es) Mutaciones del gen PIK3CA en cánceres humanos
BRPI1004572A2 (pt) "fusões genéticas recorrentes em câncer
SG165353A1 (en) Improved human interferon molecules and their uses
PT2601961T (pt) Composições compreendendo lag-3 e anticorpos terapêuticos e as suas utilizações no tratamento de cancro
DK2068909T3 (da) Modificerede FGF-21-polypeptider og anvendelse heraf
IL202213A0 (en) Recombinant protein production in avian ebxr cells
EP2038041A4 (de) Therapeutische verbindungen und ihre verwendung bei krebs
PL2532679T3 (pl) Ludzkie przeciwciała przeciwko IL13 i zastosowania terapeutyczne
PL2100618T3 (pl) Przeciwciało anty-PDGFR alfa do zastosowania w leczeniu przerzutowego raka kości
IL191999A0 (en) Targeting gli proteins in human cancer by small molecules
PL2173337T3 (pl) Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę
IL196673A0 (en) Recombinant human interferon-like proteins
DK3401327T3 (da) Genprodukter med forskellig ekspression i tumorer og anvendelser deraf
SI2139917T1 (sl) Anti-androgeni peptidi in njihove uporabe v zdravljenju raka
IL202413A0 (en) Puro-dhfr marker and its use in protein production
DE602006021315D1 (de) Gen und polypeptid in zusammenhang mit brustkrebs
ZA200606216B (en) Modified human interferon polypeptides and their uses
ATE505561T1 (de) Gen und polypeptid in zusammenhang mit brustkrebs
DE602006020451D1 (de) Gene und polypeptide mit bezug zu prostatakrebs
AP2007004141A0 (en) Recombinant expression of defensins in filamentousfunti
EP1922328A4 (de) Auf proteinkinase c isoformen abgezielte peptide und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties